Prevymis 240 mg/12 ml, Konzentrat zur Herstellung einer Infusionslösung

7680666530016 CH-66653 Konzentrat
Prevymis 240 mg/12 ml, Konzentrat zur Herstellung einer Infusionslösung
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
letermovirum
240.0 MG Substance Wirkstoff (Principe actif)
hydroxypropylbetadexum
1800.0 MG Substance HBESI
natrii chloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
22.9 MG Substance HBESI

Reimbursement information

Public price
CHF 181.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2020

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
66653
Drug name
Prevymis, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
LSMP
ATC Code
J05AX18
Authorization status
Z
Dispensing category
A
First authorization
05/04/2018
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
Cytomegalovirus-(CMV)-Prophylaxe

Package details

Description (FR)
PREVYMIS 240 mg/12 ml sol inj 240 mg 1 pce
Description (DE)
PREVYMIS 240 mg/12 ml Inj Lös 240 mg 1 Stk
Market launch
05/04/2018
Narcotic (BTM)
No

Other package sizes (1)

PREVYMIS 480 mg/24 ml sol inj 480 mg 1 pce
1 DUR
GTIN: 7680666530023
View
Buy us a coffee Explore the data